News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,713 Results
Type
Article (87950)
Company Profile (826)
Press Release (780920)
Multimedia
Podcasts (194)
Webinars (28)
Section
Business (233257)
Career Advice (4146)
Deals (39876)
Drug Delivery (150)
Drug Development (91413)
Employer Resources (204)
FDA (18385)
Job Trends (17426)
News (397900)
Policy (39968)
Tag
Academia (3010)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (145)
Alliances (56981)
ALS (180)
Alzheimer's disease (1787)
Antibody-drug conjugate (ADC) (343)
Approvals (18557)
Artificial intelligence (620)
Autoimmune disease (155)
Automation (35)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (200)
Biotechnology (491)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (653)
Cancer (4984)
Cardiovascular disease (437)
Career advice (3569)
Career pathing (41)
CAR-T (302)
CDC (59)
Celiac Disease (1)
Cell therapy (820)
Cervical cancer (37)
Clinical research (76954)
Collaboration (1780)
Company closure (5)
Compensation (1145)
Complete response letters (70)
COVID-19 (2989)
CRISPR (98)
C-suite (841)
Cystic fibrosis (154)
Data (6197)
Decentralized trials (2)
Denatured (71)
Depression (149)
Diabetes (529)
Diagnostics (7217)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (298)
Drug pricing (222)
Drug shortages (36)
Duchenne muscular dystrophy (236)
Earnings (100082)
Editorial (63)
Employer branding (25)
Employer resources (173)
Events (135020)
Executive appointments (1028)
FDA (21515)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1540)
Gene editing (212)
Generative AI (63)
Gene therapy (663)
GLP-1 (1114)
Government (5437)
Grass and pollen (8)
Guidances (383)
Healthcare (20942)
HIV (60)
Huntington's disease (48)
IgA nephropathy (86)
Immunology and inflammation (288)
Immuno-oncology (57)
Indications (87)
Infectious disease (3275)
Inflammatory bowel disease (203)
Inflation Reduction Act (17)
Influenza (118)
Intellectual property (242)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5199)
Job search strategy (2866)
JPM (64)
Kidney cancer (17)
Labor market (91)
Layoffs (659)
Leadership (40)
Legal (10159)
Liver cancer (98)
Longevity (14)
Lung cancer (676)
Lymphoma (375)
Machine learning (44)
Management (66)
Manufacturing (835)
MASH (172)
Medical device (15015)
Medtech (15063)
Mergers & acquisitions (22971)
Metabolic disorders (1378)
Multiple sclerosis (160)
NASH (23)
Neurodegenerative disease (351)
Neuropsychiatric disorders (95)
Neuroscience (3089)
Neurotech (1)
NextGen: Class of 2026 (7707)
Non-profit (5110)
Now hiring (64)
Obesity (664)
Opinion (334)
Ovarian cancer (166)
Pain (203)
Pancreatic cancer (230)
Parkinson's disease (293)
Partnered (39)
Patents (496)
Patient recruitment (468)
Peanut (60)
People (66853)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23786)
Phase II (33385)
Phase III (25170)
Pipeline (4842)
Policy (333)
Postmarket research (3554)
Preclinical (10688)
Press Release (72)
Prostate cancer (241)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (880)
Real estate (7439)
Recruiting (80)
Regulatory (28943)
Reports (66)
Research institute (2722)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (157)
Series A (256)
Series B (194)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (99)
The Weekly (121)
Vaccines (1140)
Venture capital (94)
Weight loss (457)
Women's health (85)
Worklife (21)
Date
Today (66)
Last 7 days (382)
Last 30 days (2127)
Last 365 days (32992)
2026 (2024)
2025 (33228)
2024 (38142)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (88)
Alaska (7)
Arizona (340)
Arkansas (14)
Asia (51528)
Australia (9045)
California (11423)
Canada (3287)
China (1150)
Colorado (484)
Connecticut (496)
Delaware (343)
Europe (118374)
Florida (1668)
Georgia (368)
Hawaii (4)
Idaho (68)
Illinois (956)
India (66)
Indiana (540)
Iowa (24)
Japan (420)
Kansas (133)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1448)
Massachusetts (8430)
Michigan (354)
Minnesota (662)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (124)
New Hampshire (85)
New Jersey (3080)
New Mexico (33)
New York (3024)
North Carolina (1597)
North Dakota (10)
Northern California (5452)
Ohio (349)
Oklahoma (22)
Oregon (54)
Pennsylvania (2289)
Puerto Rico (21)
Rhode Island (50)
South America (1661)
South Carolina (64)
South Dakota (1)
Southern California (4406)
Tennessee (175)
Texas (1805)
United States (41280)
Utah (342)
Vermont (1)
Virginia (285)
Washington D.C. (87)
Washington State (960)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
There are 869,713 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
January 27, 2026
·
7 min read
Manufacturing
Big Pharma Tight-Lipped on Details of API Stockpile Deals
Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are keeping many of the terms of their agreements private.
January 27, 2026
·
4 min read
·
Nick Paul Taylor
Opinion
FDA Inspections Should Not Be Source of Stress
True inspection readiness is about the integrity of a company’s entire system.
January 27, 2026
·
5 min read
·
Greg Walker
Press Releases
Nxera Pharma Webinar Presentation for FY2025 Financial Results
January 26, 2026
·
2 min read
Events
Register: 2026 Hiring Trends and Job Market Signals
This webinar will provide a clear-eyed assessment of current hiring conditions across biopharma, exploring which roles and skills are in demand, where opportunities are emerging, and how hiring practices are evolving.
January 26, 2026
Press Releases
Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference
Phio’s Presentation to take place on Wednesday January 28, 2026 at 9 AM ET
January 26, 2026
·
4 min read
Press Releases
Optimi Health Completes First 2026 Production of MDMA and Psilocybin Capsules
Australia’s Department of Health has issued import permits for Optimi’s MDMA and psilocybin capsules for use under the Authorised Prescriber Scheme
January 26, 2026
·
1 min read
Press Releases
Organoid : Organ or Model? Navigating the Scientific Hype - Commentary by Unexakorea
January 26, 2026
·
1 min read
Press Releases
BlueOcean Global Announces FDA 510(k) Clearance of the Excelsior™ External Fixation System
January 26, 2026
·
1 min read
Press Releases
L7 Informatics: Life Sciences Must Move from AI-Ready to AI-Actionable
Execution layers are required to turn AI recommendations into governed action in regulated workflows.
January 26, 2026
·
1 min read
1 of 86,972
Next
